Association of LAPTM4B gene polymorphism with breast cancer susceptibility.

BACKGROUND Lysosome associated protein transmembrane 4 beta (LAPTM4B) was a cancer-associated gene that is mapped to chromosome 8q22 with seven exons and six introns. LAPTM4B gene polymorphism has been reported to be significantly associated with susceptibility of several solid tumors. METHODS We performed a case-control study was to investigate the association between LAPTM4B polymorphism and the risk of breast cancer in 732 breast cancer patients and 649 controls. RESULTS A significant difference in the frequency of LAPTM4B*2 was observed between the patients and the controls (P < 0.01). Using the LAPTM4B*1/1 genotype as a reference, we found that LAPTM4B allelic variation was significantly associated with breast cancer occurrence, with adjusted odds ratios of 1.387 (95%CI = 1.111-1.730) for LAPTM4B*1/2 and 1.592 (95% CI = 1.043-2.430) for LAPTM4B*2/2 genotype. CONCLUSION Our results suggested that LAPTM4B*2 is associated with an increased risk of breast cancer in the Chinese women population and may be a risk factor of breast cancer.

[1]  Qinghua Zhou,et al.  [Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer]. , 2006, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[2]  M. McNutt,et al.  LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. , 2008, Oncology reports.

[3]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[4]  Jun Liu,et al.  Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma , 2003, Oncogene.

[5]  Lin Sun,et al.  The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects , 2010, Breast Cancer Research and Treatment.

[6]  David J. Anderson,et al.  Identification of a cell type‐specific silencer in the first exon of the His‐1 gene , 2000, Journal of cellular biochemistry.

[7]  J. Rui,et al.  Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. , 2010, American journal of surgery.

[8]  Jing He,et al.  [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[9]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[10]  J. Rui,et al.  Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. , 2008, Cancer letters.

[11]  Chen-Yang Shen,et al.  Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. , 2009, Carcinogenesis.

[12]  P. Boyle,et al.  World Cancer Report 2008 , 2009 .

[13]  X. Nie,et al.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma , 2010, Journal of Cancer Research and Clinical Oncology.

[14]  Benjamin O. Anderson,et al.  Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative , 2008, World Journal of Surgery.

[15]  Y. Liu,et al.  Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  J. Rui,et al.  [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[17]  Ming-zhu Yin,et al.  LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma , 2010, International Journal of Gynecologic Cancer.

[18]  Ming-zhu Yin,et al.  Correlation of LAPTM4B polymorphisms with cervical carcinoma , 2011, Cancer.

[19]  I. Petersen,et al.  The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. , 2005, Cancer letters.

[20]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[21]  Roman Rouzier,et al.  Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.

[22]  Keda Yu,et al.  Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects , 2010, Breast Cancer Research and Treatment.

[23]  W. Xu,et al.  Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  H. Li,et al.  LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling , 2010, Oncogene.

[25]  Zoltan Szallasi,et al.  Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer , 2010, Nature Medicine.

[26]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.